Cannabis use linked to doubled heart attack risk in diabetic patients

Elevated Cardiovascular Risk and Mortality in Type 2 Diabetes Mellitus Patients With Cannabis, Opioid, and Cocaine Use Disorders.

Diabetes, obesity & metabolism • • Moderately Relevant
🤖

AI Summary

This study examined how cannabis use disorder (along with opioid and cocaine use disorders) affects cardiovascular health and mortality risk in patients with type 2 diabetes. Researchers analyzed data from nearly 70,000 matched pairs of diabetic patients over a 3-year period, comparing those with substance use disorders to those without. The findings revealed substantially elevated risks: patients with cannabis use disorder experienced nearly double the risk of heart attack and significantly higher rates of atrial fibrillation, heart failure, and stroke compared to matched controls.

The research demonstrates that cannabis use disorder is strongly associated with cardiovascular complications in diabetic patients, with particularly concerning implications for mortality. Over the follow-up period, substance use disorder patients showed a 42% increased risk of death from any cause. It's important to note that opioid-related disorders carried the highest mortality risk, though cannabis use disorder showed consistent elevations across all cardiovascular outcomes. The study employed rigorous statistical matching to account for differences between groups, though researchers acknowledge that some unmeasured factors could influence the results.

These findings underscore an important public health message: individuals with diabetes who use cannabis should be aware of potential additional cardiovascular risks and work closely with healthcare providers for enhanced monitoring and preventive strategies. The combination of diabetes and cannabis use disorder appears to create a particularly high-risk situation for heart disease and early death, highlighting the need for integrated medical care that addresses both metabolic and substance use factors."

📄 Original Abstract

To evaluate the association between substance use disorders (SUDs), cardiovascular disease (CVD), and all-cause mortality in patients with type 2 diabetes mellitus (T2DM). Using the TriNetX Research Network, we performed a retrospective cohort analysis of adults aged ≥ 18 years diagnosed with T2DM between January 2016 and December 2022. Patients diagnosed with cannabis-, opioid-, or cocaine-related disorders within 1 year prior to their T2DM diagnosis were identified. Propensity score matching (PSM) was utilized to balance demographics, comorbidities, and medication use between the SUD and non-SUD cohorts. After PSM, each group included 69 419 individuals. Over a 3-year follow-up period, the SUD cohort exhibited significantly elevated risks of acute myocardial infarction (HR 1.994; 95% CI 1.766-2.253), atrial fibrillation (HR 1.455; 95% CI 1.300-1.630), heart failure (HR 1.837; 95% CI 1.693-1.994), stroke (HR 1.524; 95% CI 1.354-1.715), and all-cause mortality (HR 1.420; 95% CI 1.359-1.483). Subgroup analyses demonstrated consistent risk elevations across all substance types, with the highest relative mortality risk observed in patients with opioid-related disorders. All associations were statistically significant (p < 0.001). Co-occurring SUDs are strongly associated with increased risk of cardiovascular morbidity and all-cause mortality in T2DM patients. However, these associations should be interpreted cautiously due to potential residual confounding despite propensity score matching. These findings underscore the urgent need for integrated risk assessment alongside tailored preventive and therapeutic strategies in this high-risk population.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.